Zacks Investment Research on MSN
LivaNova reports improved OSA outcomes with PolySync programming
LivaNova LIVN recently announced new data from the PolySync substudy showing that its PolySync programming algorithm ...
LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be ...
LivaNova (Nasdaq:LIVN) today announced new data demonstrating the success of its PolySync programming algorithm for sleep ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced new data showing that use of its PolySync™ programming algorithm increased the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced new data showing that use of its PolySync™ programming algorithm increased the cumulative apnea-hypopnea index ...
LivaNova's PolySync algorithm raised the AHI response rate to 84.5% in moderate to severe OSA patients. LivaNova shares slipped 0.3% after the news but remain up 29.1% YTD against an industry fall.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results